Status:
COMPLETED
Flurbiprofen Axetil for Uterine Contraction Pain
Lead Sponsor:
Nanjing Medical University
Conditions:
Postoperative Pain
Eligibility:
FEMALE
19-45 years
Phase:
PHASE4
Brief Summary
Uterine contraction pain is a common problem after abortion. Optimal analgesic for such suffering is still needed to be guaranteed. Flurbiprofen Axetil is a target-distributable non-steroidal anti-inf...
Eligibility Criteria
Inclusion
- ASA status I-II
- Performing abortion operation (medical- or drug-induced
- Requiring painless abortion
Exclusion
- \< 19yrs, and \>= 45yrs
- History of central active drugs administration
- Drug abuse
- Hypertension
- Diabetes
- Any other chronic diseases
- Allergy to the study drugs
- Habit of over-volume alcohol drinking
- Records of history of centrally active drug use and psychiatry
- Any organic disorders
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00725218
Start Date
May 1 2008
End Date
August 1 2008
Last Update
August 6 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing Maternal and Child Health Care Hospital
Nanjing, Jiangsu, China, 210004